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Ultrasonic irradiationAbstract Dihydropyrimidinone derivatives were prepared by tri-component reaction of ethyl
aceto acetate, aldehydes and thiourea in the presence of modiﬁed montmorillonite nanostructure
as a catalyst and used as key intermediates for the synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoe-
thylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyri midine-6-carboxylate derivatives
with use of diethyl and dimethyl acetylene dicarboxylate by two methods: (a) in methanol as a sol-
vent under ultrasonic irradiation at ambient temperature (b) in methanol as a solvent at ambient
temperature (conventional magnetic stirring). Ultrasound-assisted synthesis provides excellent
yields in short reaction times (15–25 min) at room temperature.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Dihydropyrimidinone derivatives have attracted considerable
interest in recent years because of therapeutic and pharmaco-
logical properties nowadays. For example, they can serve as
the integral backbones of several calcium channel blockers(Rovnyak et al., 1995; Aswal et al., 1990), antihypertensive
agents (Atwal et al., 1991; Grover et al., 1995) and
a-1a-antagonists (Kappe, 2000a,b). In addition, several marine
alkaloids containing the dihydropyrimidinone-5-carboxylate
motifs also show interesting biological activities (Overman
et al., 1995). Substituted 3, 4-dihydropyrimidines a and 3,
4-dihydro-1, 3-oxazines b are regarded as promising synthons
in the design of new bioactive compounds (Scheme 1). For
instance, structural scaffold a is represented by poly functional
3,4-dihydropyrimidines known as Biginelli compounds
(Kappe, 1993, 2000a,b) which include a number of antiviral,
anti-bacterial, anti-hypertensive, and anti-inﬂammatory agents
(Kappe, 2000a,b).
Many pyrimidine derivatives have been reported to possess
useful medicinal and biological activities (Barton and Ollis,
1974; Brown et al., 1984; Sasaki et al., 1980; Griengl et al.,l-3-oxo-
Scheme 1
2 A. Darehkordi, S. Ghazi1987). In the last few years, various pyrimidinone and pyrimid-
inone derivatives substituted either at C-5 or at C-6 positions
have emerged in the ﬁeld of chemotherapy (Scheme 2)
(Parlato et al., 2004). Recently, the pyrimidinone derivatives
2-methylthio-6-[(2-alkylamino) ethyl]-4(3H)-pyrimidinones
have been shown to posses activity against positive strand
(vesicular stomatitis virus) RNA virus (Scheme 2) (Botta
et al., 1999).
A series of 1-(biphenylmethylamidoalkyl) pyrimidinones
have also been designed as nano molar inhibitors of recombi-
nant lipoprotein-associated phospholipase A2 with high
potency in whole human plasma. Also, thienopyrimidine
derivatives have been reported to possess useful molluscidal,
larvacidal activities against Biomphalaria alexandrina and
Schistosoma mansoni, snails.Scheme
Table 1 The effect of different solvent and temperature on the rea
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temperature
Solvent Temperature (C)
Dichloromethane 30
Dichloromethane Reﬂux
Dichloromethane Reﬂux
Ethyl acetate + H2O 30
Ethyl acetate 30
H2O 60
Ethanol 30
Methanol 30
Methanol 30
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for C–C bond formation and has been successfully employed
for the synthesis of a number of furo [3, 2-d] pyrimidines, pyr-
ano [3, 2-d] pyrimidines and dihydrofuro [2, 3-d] pyrimidine
derivatives (Kawahara et al., 1985; Majumdar and Das,
1997), there are hardly many reports in the pyrimidinone ser-
ies. Previously synthesis and characterization of pyrimidi-
none-peptoid hybrid molecules that modulate Hsp70 activity
in vitro and that, in some cases, prevent cancer cell prolifera-
tion have been reported (Wright et al., 2008; Fewell et al.,
2004, 2001; Rodina et al., 2007). Recently we have reported
synthesis a series of thiazoline compounds from reaction of thi-
osemicarbazone derivatives of aldehydes and ketoses with
alkyl acetylenic esters (Darehkordi et al., 2007).
The sonochemistry is a unique method in chemical reac-
tions, because of cavitations, a physical process that creates,
enlarges, and implodes gaseous and vaporous cavities in an
irradiated liquid. Cavitations induce very high local tempera-
tures and pressures inside the bubbles (cavities), leading to
turbulent ﬂow of the liquid and enhanced mass transfer
(Ranjbar-karimi et al., 2010).
Ultrasound irradiation has been considered as a clean and
useful protocol in organic synthesis in the last three decades
(Xue and Li, 2008; Wang et al., 2008; Li et al., 2010), and2
ction.
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EtO N
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CO2Me
+
Time (h) Yield (%)
12 30
10 45
12 50
12 35
12 30
12 Trace
8 70
1 70
2 94
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Table 2 UV–Vis absorption of 6a–6i in DMSO at 25 C.
Entry Product kmax (nm)
1 6a 282.53, 377.20
2 6b 309.66, 402.02
3 6c 278.32, 376.62
4 6d 274.45, 380.66
5 6e 287.73, 378.35
6 6f 310.82, 395.67
7 6g 284.84, 376.6
8 6h 286.58, 384.70
9 6i 298.70, 386.43
An efﬁcient ultrasonic-assisted synthesis 3compared with traditional methods, the procedure is more
convenient. A large number of organic reactions can be carried
out in higher yield, shorter reaction time or milder conditionsTable 3 Synthesis of ethyl 5-(4-Alkylphenyl)-2-(2-alkoxy-2-oxoeth
dine-6-carboxylate (6a–6i).
Entry R Acetylenic ester Product
1
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Rajagopal et al., 2002; Bravo et al., 2006).
The aim of this study was the synthesis of ethyl-5-(aryl)-2-
(2-alkokxy-2-oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-
thiazolo [3, 2-a] pyrimidine-6-carboxylate derivatives from
reaction of dihydropyrimidinone derivatives with dimethyl
and diethyl acetylenedicarboxylate using both ultrasonic irra-
diation method and a more conventional magnetic stirring
method.2. Results and discussion
The preparation of thiazoline compounds was developed in the
over years. In continuing our work in the synthesis of ﬁve
membered S, N-heterocyclic thiazoline (Darehkordi et al.,
2007), we wish to report other heterocyclic compounds fromylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo[3, 2-a]pyrimi-
M.P (C) Time (min) Yield
US R.T US R.T
S
O
CO2Me
154–155 25 120 95 92
S
O
CO2Et
167–169 23 120 97 95
S
O
CO2Me
131–132 24 125 96 94
S
O
CO2Et
170–173 25 128 95 93
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Table 3 (continued)
Entry R Acetylenic ester Product M.P (C) Time (min) Yield
US R.T US R.T
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4 A. Darehkordi, S. Ghazipyrimidinone derivatives. In our earlier studies, we have
reported reaction of thiosemicarbazone derivatives with
DAMAD and DEAD at ambient temperature. Herein, we
have reacted DMAD and DEAD with different dihydropyrim-
idine-2-(1H)-ones using both ultrasonic irradiation method
and a conventional method.
Initially, we started the condensation of DMAD
(0.001 mol) with ethyl 4-(4-methoxyphenyl)-6-methyl-2-
thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (0.001 mol)
in dichloromethane at room temperature for 12 h. This led
to poor yield (30%) of ethyl-5-(4-methoxyphenyl)-2-(2-meth-Please cite this article in press as: Darehkordi, A., Ghazi, S. An eﬃcient ultrasonic-as
3, 5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate derivatives. Arabian Jouroxy-2-oxoethylidene)-7-methyl-3-oxo-3,5-dihydro- 2H-thiazol-
o[3,2-a]pyrimidine-6-carboxylate(6c). To enhance the yield of
the reaction, temperature was increased to 60 C but no appre-
ciable increment was observed in the product yield. Choice of
solvent is also very crucial factor for condensation reaction.
We also considered the solvent effect for this reaction. The
reaction was tested in a variety of solvents such as H2O,
EtOAC, H2O-EtOAC and EtOH, but none of the above sol-
vents were found to be more effective than methanol (Table 1).
Since water exhibits a unique reactivity and selectivity different
from conventional organic solvents, the reaction was alsosisted synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)- 7-methyl-3-oxo-
nal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.01.010
Scheme 3 Suggested mechanism for the synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-
thiazolo [3, 2-a] pyrimidine-6-carboxylate derivatives.
Scheme 4 Synthesis of pyrimidine derivatives under solvent-free conditions.
Scheme 5 Synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo [3,2-a]pyrimidine-6-car-
boxylate derivatives.
Scheme 6 Synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo[3, 2-a]pyrimidine-6-car-
boxylate derivatives under ultrasonic irradiation.
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6 A. Darehkordi, S. Ghazicarried out in water. Nevertheless, the reaction, at 60 C, did
not give the desired product and the starting material was
recovered, whereas after a prolonged reaction (12 h) at
100 C, only trace of the desired products was identiﬁed by
TLC. It was identiﬁed that methanol and ethanol, especially
methanol were a choice for the reaction and the desired prod-
uct was obtained in methanol at 30 C in excellent yield
(Tables 1 and 3).
In this pursuit we ﬁrst examined the reaction of pyrimidi-
none derivative 4a with dimethyl acetylenedicarboxylate in
ethanol at ambient temperature. This led to excellent yield
(92%) of ethyl-5-(4-methoxyphenyl)-2-(2-methoxy-2-oxoethy-
lidene)-7-methyl-3-oxo-3,5-dihydro- 2H-thiazolo[3,2-a]pyrimi-
dine-6-carboxylate 6c at 120 min. First of all, we studied
the conventional magnetic stirring for the synthesis of
ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)-7-methyl-3-oxo-3,
5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate deriv-
atives. In general, the desire products were isolated in excel-
lent yields without puriﬁcation (Scheme 5 Table 3).
To improve our studies, and in order to decrease the reac-
tion times and increase the yield, the synthesis of the same
compounds 6a–6i was carried out using ultrasound irradia-
tion, at room temperature. In the ﬁrst, we examined the
reaction of pyrimidinone derivative 4a with dimethyl acety-
lenedicarboxylate promoted by ultrasound in ethanol to give
the corresponding 5-(4-cholorophenyl)-2-(2-methoxy-2-oxoe-
thylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo [3, 2-a]
pyrimidine-6-carboxylate 6a in excellent yield (95%) only in
25 min (Table 3, entry 1). Therefore all of the compounds
6a–6i were synthesized using ultrasound irradiation, at room
temperature, shorter reaction times and excellent yields. The
ultrasonic method was simpler and the products were isolated
without further puriﬁcation (Scheme 6 Table 3).
As therein revealed, using conventional magnetic stirring,
the resulting product was obtained with 92% yield after
120 min (Table 3, entry 1); however, under ultrasonic irradi-
ation, with the power 360 W, irradiation frequency 47 kHz
and the reaction temperature 27–30 C, the excellent prod-
ucts yield (95%) was obtained after only 20 min (Table 3,
entry 1). To establish the generality of the ultrasonic-assisted
reaction, a series of dihydropyrimidinone derivatives were
employed in this reaction, and the results are listed in
Table 3.
The reaction is mainly condensation which fallowed by
cyclization. Initially the sulfur atom from dihydropyrimidi-
none attacks to the carbon triplet bond of acetylenic ester com-
pound which is the prone to nucleophilic attack. Then
cyclization proceeds on to the esoteric (CO2R) function to give
products 6 and 7 in excellent yield (Scheme 5). A plausible
mechanism has been proposed for the reactions of
pyrimidinone derivatives with DMAD and DEAD to yield
ethyl-5-(aryl)-2-(2-alkoxy-2-oxoethylidene)-7-methyl-3-oxo-3,
5-dihydro-2H thiazolo [3,2a] py- rimidine-6-carboxylate deriv-
atives as shown in Scheme 3.
Compounds 6a–6i are yellow or orange solid. The UV–Vis-
ible absorption of these products demonstrates major absorp-
tion in wavelength ranges of 278.32–402.02 nm in DMSO
solvent at room temperature as indicated in Table 2.
Table 3 shows the stricture and yield of the ethyl 5-(4-
Alkylphenyl)-2-(2-Alkoxy-2-oxoethylidene)-7-methyl-3-oxo-3,
5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate deriv-
ative (6a–6i).Please cite this article in press as: Darehkordi, A., Ghazi, S. An eﬃcient ultrasonic-as
3, 5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate derivatives. Arabian JourThe structure of compound ethyl 5-(4-Alkylphenyl)-2-
(2-Alkoxy-2-oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-
thiazolo [3, 2-a] pyrimidine-6-carboxylate was deduced from
their 1H and 13C NMR, UV–Vis and elemental analysis.
3. Experimental section
3.1. Apparatus
A multiwave ultrasonic generator (Bandlin Sonopuls Gerate-
Typ: UW 3200, Germany) equipped with a converter/trans-
ducer and titanium oscillator (horn), 12.5 mm in diameter,
operating at 50 kHz with a maximum power output of
780 W, was used for the ultrasonic irradiation. The ultrasonic
generator automatically adjusted the power level. Melting
points were determined in open capillary tubes by an Electro-
thermal IA 9000 melting point apparatus. IR spectra (KBr)
were obtained on a Matson-1000 FT-IR spectrometer. The
proton and carbon-13 NMR spectra were recorded with a
BRUKER DRX-500 AVANCE spectrometer at 500 and
125.7 MHz respectively with Me4Si as an internal standard
(chemical shifts in d, ppm). Element analyses (C, H, and N)
were performed with a Heracus CHN-O-Rapid analyzer.
UV–Vis spectra were recorded with a CARY 100 CONC spec-
trophotometer. Their results corresponded to the calculated
values within experimental error. TLC was performed on silica
gel PolyGram SIL G/UV 254 plates. The starting materials
were purchased from Merck and used without further
puriﬁcation. All yields refer to isolated products. Pyrimidine
derivatives were synthesized by following procedure:
A mixture of ethyl acetoacetate or acetyl acetone 2
(2 mmol), appropriate aldehyde 1 (2 mmol), thiourea 3
(3 mmol) and montmorillonite catalyst (0.6 g) was placed in
a test tube and heated in a bathe oil under solvent free condi-
tions, for 120 min (Scheme 4). After cooling the reaction mix-
ture, ethanol was added to that and catalyst was removed by
ﬁltration. The ﬁltrate was poured into the crushed ice water
and the resulting precipitate recrystallized from hot ethanol
to afford pure product. All of the compounds were character-
ized by MP, FT-IR, 13C and 1H NMR, UV–Vis spectropho-
tometer and elements analysis.
3.2. General procedure for synthesis of ethyl-5-(4-choloro-
phenyl)-2-(2-methoxy-2-oxoethylidene)-7-methyl-3-oxo-3,
5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate (6a)
A solution of DMAD (0.001 mol, 0.140 g) or DEAD
(0.001 mol, 0.172 g) in 3 ml methanol was added to a solution
of pyrimidinones derivatives (0.001 mol, 0.346 g) in methanol
(10 cc) in small portions. Mixture was stirred at ambient tem-
perature for 2 h. The resulting yellow precipitate was ﬁltered
and washed with cold methanol or ethanol. The product was
obtained without puriﬁcation as yellow powder (Scheme 5).
3.3. General procedure for synthesis of ethyl-5-(4-
cholorophenyl)-2-(2-methoxy-2-oxoethylidene)-7-methyl-3-
oxo-3, 5-dihydro-2H-thiazolo [3, 2-a] pyrimidine-6-carboxylate
under ultrasonic irradiation (6a)
A solution of DMAD (0.001 mol, 0.140 g) or DEAD
(0.001 mol, 0.172 g) in 3 ml methanol was added to a solutionsisted synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)- 7-methyl-3-oxo-
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An efﬁcient ultrasonic-assisted synthesis 7of pyrimidinones derivatives (0.001 mol, 0.346 g) in methanol
(4 cc) in small portions. This reaction mixture was sonicated
at 45 kHz. After the completion of reaction as indicated by
TLC, the reaction mixture was ﬁltered. The resulting yellow
precipitate was ﬁltered and washed with cold methanol or eth-
anol. The product was obtained without puriﬁcation as yellow
powder (Scheme 6).
3.4. Commentary and spectra
3.4.1. Ethyl-5-(4-cholorophenyl)-2-(2-methoxy-2-
oxoethylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo
[3, 2-a] pyrimidine-6-carboxylate (6a)
Yellow powder, m.p.: 150–155 C, IR KBr ( , cm1): 2978,
2959 (CAH, aliphatic), 3057 (CAH, aromatic), 1728, 1711
(C‚O), 1617, 1489 (C‚N, C‚C). 1H NMR (DMSO-d6,
500 MHz); d 1.09 (t, J= 7.0 H, 3H, CH3), 2.37 (s, 3H,
CH3), 3.77 (s, 3H, OCH3), 4.03 (q, J= 7.0 Hz, 2H, OACH2),
5.97 (s, 1H, CH), 6.83 (s,1H, CH), 7.30 (d, J= 5 Hz, 2H, arom
CH), 7.39 (d, J= 5 Hz, 2H, arom CH). 13C NMR (DMSO-d6,
125.77 MHz): d= 13.71 (1C, CH3, CH3), 22.21 (1C, CH3,
CH3), 52.73 (1C, CH, CH‚N), 54.53 (1C, CH3, OCH3),
60.30 (1C, CH2, OACH2), 117.48, 128.59, 129.60, 133.19,
138.29, 139.18, 150.34, 155.41, 162.71, 164.44, 165.66. Anal.
Calcd for C19H17 N2O5SCl: C, 54.22; H, 4.07; N, 6.66. Found:
C, 54.49; H, 4.23; N, 6.87%.
3.4.2. Ethyl-5-(4-cholorophenyl)-2-(2-ethoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo
[3,2-a]pyrimidine-6-carboxylate (6b)
Yellow powder, m.p.: 144–147 C, IR KBr ( , cm1): 2908,
2986 (CAH, aliphatic), 3070 (CAH, aromatic), 1729, 1708
(C‚O), 1628, 1487 (C‚N, C‚C). 1H NMR (DMSO-d6,
500 MHZ): d= 1.1 (t, J= 7.0 Hz, 3H, CH3), 1.25 (t,
J= 7.0 Hz, 3H, CH3), 2.39 (s, 3H, CH3), 4.05 (q,
J= 7.0 Hz, 2H, OCH2), 4.23 (q, J= 7.0 Hz, 2H, OCH2),
5.99 (s, 1H, CH), 6.83 (s, 1H, CH), 7.32 (d, J= 7.0 Hz, arom
CH) , 7.42(d, J= 7.0 Hz, arom CH). 13C NMR (DMSO-d6,
125.77 MHz): d= 14.69 (1C, CH3), 14.80 (1C, CH3), 23.19
(1C, CH3), 55.47 (1C, OACH2), 61.27 (1C, OACH2), 62.71
(1C, OACH2), 118.72, 129.57, 130.58, 134.13, 139.29, 140.03,
151.312, 156.46, 163.69, 165.41, 166.12. Anal. Calcd for
C20H19N2O5SCl: C, 55.24; H, 4.40; N, 6.30%. Found; C,
55.36; H, 4.66; N, 6.42%.
3.4.3. Ethyl-5-(4-methoxyphenyl)-2-(2-methoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo
[3,2-a]pyrimidine-6-carboxylate (6c)
Yellow powder, m.p.: 129–132 C, IR KBr ( , cm1): 2981
(CAH, aliphatic), 3064 (CAH, aromatic), 1720, 1711 (C‚O),
1611, 1464 (C‚N, C‚C). 1H NMR (DMSO-d6, 500 MHz):
d= 1.1 (t, J= 7.0 Hz, 3H, CH3), 2.38 (s, 3H, CH3), 3.71 (s,
3H, OCH3), 3.78 (s, 3H, OCH3) , 4.03 (q, J= 7.0 Hz, 2H,
OACH2) , 5.95 (s, 1H, HCAN), 6.88 (s, 1H, CH‚C), 6.90
(d, J= 8.6 Hz, arom CH), 7.2 (d, J= 8.6 Hz, arom CH).
13C NMR (DMSO-d6, 125.77 MHz): d= 14.72 (1C, CH3),
23.07 (1C, CH3), 53.71 (1C, CH3), 55.43 (1C, OACH3),
55.96 (1C, CH), 61.18 (1C, CH2), 118.27, 129.88, 132.45,
140.30, 150.67, 156.14, 160.18, 163.69, 165.59, 166.69. Anal.Please cite this article in press as: Darehkordi, A., Ghazi, S. An eﬃcient ultrasonic-as
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C, 57.98; H, 5.01; N, 6.79%.
3.4.4. Ethyl-5-(4-methoxyphenyl)-2-(2-ethoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo
[3,2-a]pyrimidine-6-carboxylate (6d)
Yellow powder, m.p.: 167–173 C, IR KBr ( , cm1): 2958
(CAH, aliphatic), 3066 (CAH, aromatic), 1728, 1703 (C‚O),
1612, 1463 (C‚N, C‚C). 1H NMR (DMSO-d6, 500 MHz):
d= 1.12 (t, J= 7.1 Hz, 3H, CH3), 1.25 (t, J= 7.1 Hz, 3H,
CH3), 2.39 (s, 3H, CH3), 3.72 (s, 3H, OCH3), 4.04 (q,
J= 7.1 Hz, 2H, OACH2), 4.25 (q, J= 7.1 Hz, 2H, OACH2),
5.95 (s, 1H, CH, HCAN), 6.82 (s, 1H, CH), 6.90 (2H, arom
CH), 7.20 (2H, arom CH). Anal. Calcd for C21H22 N2O6S:
C, 58.59; H, 5.15; N, 6.51. Found; C, 58.77; H, 5.36; N, 6.67%.
3.4.5. Ethyl-5-(4-methylphenyl)-2-(2-methoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo
[3,2-a]pyrimidine-6-carboxylate (6e)
Yellow powder, m.p.: 192–197 C, IR KBr ( , cm1): 2981,
2957 (CAH, aliphatic), 3058 (CAH, aromatic), 1719, 1712
(C‚O), 1615, 1437 (C‚N, C‚C); 13C NMR (DMSO-d6,
125.77 MHz): d= 14.71 (1C, CH3), 21.55 (1C, CH3), 23.08
(1C, OCH3), 53.70 (1C, OCH3), 55.75 (1C, CH), 61.20 (1C,
OACH2), 118.31, 128.37, 130.11, 137.54, 139.01 , 150.73,
156.25, 163.65, 165.58, 166.67. Anal. Calcd for C20H20N2O5S:
C, 59.99; H, 5.03; N, 7.00. Found; C, 60.29; H, 5.26 N, 7.14%.
3.4.6. Ethyl-5-(4-methylphenyl)-2-(2-ethoxy-2-oxoethylidene)-
7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-
carboxylate (6f)
Yellow powder, m.p.: 169–174 C, IR KBr ( , cm1): 2985,
2969 (CAH, aliphatic), 3067 (CAH, aromatic), 1727, 1708
(C‚O), 1621, 1445 (C‚N, C‚C); 1H NMR (DMSO-d6,
500 MHz): d= 1.14 (t, J= 7.0 Hz, 3H, CH3) , 1.25 (t,
J= 7.0 Hz, 3H, CH3) , 2.25 (s, 3H, CH3) , 2.38 (s, 3H, CH3)
, 4.04 (q, J= 7.1 Hz, 2H, OACH2), , 4.21 (q, J= 7.1 Hz,
2H, OACH2), 5.96 (s, 1H, HCAN), 6.81 (s, 1H, CH‚C),
7.13–7.17 (4H, arom CH). 13C NMR (DMSO-d6,
125.77 MHz): d= 14.71 (1C, CH3), 14.80 (1C, CH3), 21.55
(1C, CH3), 23.07(1C, CH3), 55.74 (1C, CH), 61.19 (1C,
OACH2), 62.68 (1C, OACH2), 118.59, 128.36, 130.11,
137.55, 138.99, 140.11, 150.74, 156.29, 163.66, 165.57, 166.11.
Anal. Calcd for C21H22N2O5S: C, 60.85; H, 5.35; N, 6.76.
Found; C, 61.13; H, 5.72; N, 6.80%.3.4.7. Ethyl-5-(3,4-dimethoxyphenyl)-2-(2-methoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo
[3,2-a]pyrimidine-6-carboxylate (6g)
yellow powder, m.p.: 156–160 C, IR KBr ( , cm1): 2908,
2986 (CAH, aliphatic), 3070 (CAH, aromatic), 1729, 1708
(C‚O), 1628, 1487 (C‚N, C‚C); 1H NMR (DMSO-d6,
500 MHz): d= 1.14 (t, J= 7.0 Hz, 3H, CH3), 2.39 (s, 3H,
CH3), 3.72 (s, 6H, OCH3), 3.78 (s, 3H, OCH3), 4.06 (q,
J= 7.1 Hz , 2H, OACH2), 5.95 (s, 1H, HCAN), 6.76 (d,
J= 8.4 Hz, 1H, CH), 6.83 (d, 2H, arom CH), 6.90 (d,
J= 8.4 Hz, 1H, arom CH) 13C NMR (DMSO-d6,
125.77 MHz): d= 14.77 (1C, CH3), 23.03 (1C, CH3), 53.71
(1C, CH3), 55.72 (1C, CH3), 56.32 (1C, CH3), 56.39 (1C,
CH3), 61.17 (1C, OACH2), 112.45, 112.71, 118.28, 120.59,sisted synthesis of ethyl-5-(aryl)-2-(2-alkokxy-2-oxoethylidene)- 7-methyl-3-oxo-
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8 A. Darehkordi, S. Ghazi132.85, 140.32, 149.24, 149.90, 150.60, 156.14, 163.74, 165.63,
166.67. Anal. Calcd for C21H22N2O7S: C, 56.49; H, 4.97; N,
6.27. Found; C, 56.67; H, 5.07; N, 6.13%.
3.4.8. Ethyl-5-(3,4-dimethoxyphenyl)-2-(2-ethoxy-2-
oxoethylidene)-7-methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-
a]pyrimidine-6-carboxylate (6h)
Yellow powder, mp.: 165–169 C, IR KBr ( , cm1): 2984,
2936 (CAH, aliphatic), 3058 (CAH, aromatic), 1717, 1711
(C‚O), 1622, 1464 (C‚N, C‚C); 1H-NMR (DMSO-d6,
500 MHz): d= 1.14 (t, J= 7.1 Hz, 3H, CH3), 1.25 (t,
J= 7.0 Hz, 3H, CH3), 2.39 (s, 3H, OCH3), 3.72 (s, 6H,
OCH3), 4.06 (q, J= 7.1 Hz, 2H, OACH2), 4.20 (q,
J= 7.0 Hz, 2H, OACH2), 5.95 (s, 1H, HCAN), 6.70 (1H,
arom CH), 6.83 (s, 2H, arom CH), 6.90 (1H, arom CH). Anal.
Calcd for C22H24N2O7S: C, 57.38; H, 5.24; N, 6.08. Found; C,
57.64; H, 5.36; N, 6.12%.
3.4.9. Ethyl-5-(4-phenyl)-2-(2-methoxy-2-oxoethylidene)-7-
methyl-3-oxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-
carboxylate (6i)
Yellow powder, m.p.: 165–17 0 C, IR KBr ( , cm1): 2987,
2949 (CA, aliphatic), 3062 (CAH, aromatic), 1722, 1708
(C‚O), 1617, 1464 (C‚N, C‚C); 1H NMR (DMSO-d6,
500 MHz): d= 1.11 (t, J= 7.0 Hz, 3H, CH3), 2.39 (s, 3H,
CH3), 3.78 (s, 3H, OCH3), 4.04 (q, J= 7.0 Hz, 2H, OACH2),
5.99 (s, 1H, HC-N), 6.85 (s, 1H, CH), 7.27–7.37(m, 5H, Arom
CH). 13C NMR (DMSO-d6, 125.77 MHz): d= 14.68 (1C,
CH3), 23.11 (1C, CH3), 53.70 (1C, CH3), 56.04 (1C, CH),
61.20 (1C, OACH2), 118.39, 128.47, 129.53, 129.58, 140.19,
140.43, 150.88, 156.35, 163.04, 166.66, 167.14. Anal. Calcd
for C19H18 N2O5S: C, 59.06; H, 4.70; N, 7.25. Found; C,
59.40; H, 4.86; N, 7.55%.
4. Conclusion
In conclusion, we have developed two different simple syn-
thetic methods to prepare ethyl-5-(aryl)-2-(2-alkokxy-2-oxoe-
thylidene)-7-methyl-3-oxo-3, 5-dihydro-2H-thiazolo [3, 2-a]
pyrimidine-6-carboxylate derivatives, conventional magnetic
stirring and ultrasonic irradiation. Both of the methods led
to excellent yield. Ultrasonic irradiation displays dramatically
reduced reaction time compared to conventional magnetic
stirring method, and also affords the desired products in high
yields and purity.
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